Amylyx Pharmaceuticals, Inc. (AMLX) Profit Margins
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
AMLXAmylyx Pharmaceuticals, Inc.Follow AMLX — free
—
Price chart with a free account
- Market cap
- 3.0B
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 5 Nov, in 12 days
| Line | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | TTM Jun 26 | Trend |
|---|---|---|---|---|---|---|
| Gross margin | 86.5% | 93.3% | 93.2% | — | — | |
| Operating margin | -905.7% | 10.2% | -360.2% | — | — | |
| Net margin | -892.4% | 12.9% | -345.4% | — | — | |
| FCF margin | -820.5% | 2.8% | -192.1% | — | — |
USD millions · SEC XBRL
Every figure on this page comes from Amylyx Pharmaceuticals, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.